259
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Design, synthesis and antibacterial activities of pleuromutilin derivatives

, , , &
Pages 123-137 | Received 08 Sep 2019, Accepted 06 Jan 2020, Published online: 06 Feb 2020
 

Abstract

We described the design, synthesis and antimicrobial activities of novel pleuromutilin derivatives with substituted piperazine substrate. Minimum inhibitory concentration (MIC) was used to evaluate the activity of the derivatives against six bacteria in vitro, and compound 8 was potent against Staphylococcus aureus and Staphylococcus epidermidis with the MIC value of 0.0625 μg/ml. 10a and 10 b showed similar activity to positive control drugs (tiamulin, erythromycin) against S. aureus with the MIC value of 0.125 μg/ml. The binding mode of compound 8 and tiamulin to the ribosome pocket showed the correlation between binding parameters and the antibacterial activity, and more bonds and stronger combination could effectively enhance the activity of compounds.

Graphical Abstract

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This research was funded by the Research Project of Hebei Administration of Chinese Medicine [No. 2019080], Doctor Foundation of Hebei University of Chinese Medicine [No. BSZ2018006] and Basic Research Program of Outstanding Young Teachers of Hebei University of Chinese Medicine [No. YQ2018004].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.